CDKN2A and familial pancreatic carcinoma: Five papers reported on the risk of pancreatic carcinoma in FAMMM families and discussed that families with mutations in the major melanoma gene CDKN2A should be considered for pancreatic cancer surveillance [57,58,59,60,61].